Obstructive lung diseases like COPD cause trouble when you're exhaling air. Restrictive lung diseases like pulmonary fibrosis make it harder to inhale air, reducing total lung capacity. There are two ...
"Small lung syndrome" is proposed to address persistent low lung volume linked with comorbidities, requiring a new ICD code for accurate diagnosis. Early intervention in lung function trajectories can ...
Company to continue development of efzofitimod in pulmonary sarcoidosis following Type C meeting with the FDA. Company plans ...
Company to continue development of efzofitimod in pulmonary sarcoidosis incorporating FDA feedback.Company plans to submit IND in June 2026 for ...
Company to continue development of efzofitimod in pulmonary sarcoidosis incorporating FDA feedback. Company plans to submit IND in June 2026 for new Phase 3 study of efzofitimod in patients with chron ...
22d
aTyr Pharma, Inc.: aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update
Company to continue development of efzofitimod in pulmonary sarcoidosis following Type C meeting with the FDA. Company plans to submit an IND in June 2026 for a Phase 3 study of efzofitimod in patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results